Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable stage (stg) III epidermal growth factor receptor-mutated (EGFRm) NSCLC: Primary results of the phase 3 LAURA study

Ramalingam S. S., Kato T., Dong X., Ahn M., Quang L., Soparattanapaisarn N., ...More

JOURNAL OF CLINICAL ONCOLOGY, no.17_SUPPL, 2024 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Publication Date: 2024
• Doi Number: 10.1200/jco.2024.42.17_suppl.lba4
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
• Istanbul University-Cerrahpasa Affiliated: Yes